BRITTANY BLAIR: Open Payments
NPI 1336660810 · OWINGSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,721 in 85 payments from 29 companies in 2025. Trend: 2023 $2,850 · 2024 $2,851 · 2025 $1,721
Food & beverage: $1,621Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $225 |
| Merck Sharp & Dohme LLC | 9 | $185 |
| PFIZER INC. | 9 | $172 |
| Novartis Pharmaceuticals Corporation | 9 | $159 |
| Genmab U.S., Inc. | 4 | $85 |
| Aveo Pharmaceuticals, Inc. | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Astellas Pharma US Inc | 3 | $55 |
Products named: KEYTRUDA, DARZALEX, ELREXFIO, FOTIVDA, LIBTAYO, XTANDI, KISQALI, Fabhalta.
Industry payments across KY — which companies pay providers there.
